Acciones Wayland Group Corp. Canadian Securities Exchange
Acciones
WAYL
CA9442041062
Farmacéuticos
Ventas 2016 | 4,06 5,59 3,81 | Ventas 2017 | 3,22 4,44 3,02 | Capitalización | 203 M 280 M 190 M |
---|---|---|---|---|---|
Resultado Neto 2016 | -8 M -11,02 M -7,5 M | Resultado Neto 2017 | -67 M -92,31 M -62,81 M | VE / Ventas 2016 * | - |
Deuda neta 2016 | 9,13 12,58 8,56 | Posición de caja neta 2017 | 0,42 0,58 0,39 | VE / Ventas 2017 | 63.046.727 x |
P/E ratio 2016 * |
-
| P/E ratio 2017 |
-2,13
x | Empleados | - |
Rendimiento 2016 * |
-
| Rendimiento 2017 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ben Ward
CEO | Chief Executive Officer | 44 | - |
Dan Healey
COO | Chief Operating Officer | - | - |
Steven Bennett
CTO | Chief Tech/Sci/R&D Officer | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ben Ward
CEO | Chief Executive Officer | 44 | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+39,33 % | 6013,88 M | |
-18,38 % | 4396,11 M | |
-9,17 % | 3167,65 M | |
+3,98 % | 3065,44 M | |
-3,41 % | 2507 M | |
+48,74 % | 1881,13 M | |
-4,82 % | 1730,85 M | |
-1,24 % | 1648,42 M | |
-8,96 % | 1576,81 M |